ST
VRTX icon

Stifel Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Stifel Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$18K Hold
159
– – ﹤0.01% 360
2014
Q2 		$16K Hold
159
– – ﹤0.01% 344
2014
Q1 		$12K Hold
159
– – ﹤0.01% 385
2013
Q4 		$12K Hold
159
– – ﹤0.01% 376
2013
Q3 		$13K Hold
159
– – ﹤0.01% 373
2013
Q2 		$13K Buy
+159
New +$11.7K ﹤0.01% 366

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Stifel Trust's VRTX Position: Q3 2014 in Review

Stifel Trust held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2014 at 159 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Stifel Trust first reported a position in VRTX in Q2 2013 and has held it in 6 quarters since. 430 funds tracked by Wall St. Rank hold VRTX as of Q3 2014.

  • Stifel Trust held 159 shares of Vertex Pharmaceuticals worth $18K as of Q3 2014.
  • Stifel Trust left its Vertex Pharmaceuticals share count unchanged in Q3 2014.
  • Vertex Pharmaceuticals made up ﹤0.01% of Stifel Trust's portfolio in Q3 2014, its #360 holding.
  • Stifel Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • 430 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.